¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"von Gies joint"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • humero-ulnar joint
    À§ÆÈÀÚ°üÀý
  • humeroradial joint
    À§ÆÈ³ë°üÀý
  • humeroradial joint ³ª articulatio humeroradialis
    »ó¿Ï ¿ä°ñ °üÀý(ß¾èÓèúÍéμï½), »ó¿Ï ¿ä °üÀý(ß¾èÓèúμï½),¿Ï¿ä °üÀý(èÓèúμï½).
  • humeroradial joint ³ª articulatio humeroradialis
    »ó¿Ï¿ä°ñ°üÀý, ¿Ï¿ä °üÀý(èÓèúμï½).
  • hysteric joint
    È÷½ºÅ׸®¼º °üÀý.
  • immovable joint ³ª junctura fibrosa
    ºÎµ¿ °üÀý(ÝÕÔÑμï½).
  • incudomalleolar joint
    ħÃß°ñ°üÀý.
  • incudostapedial joint
    ħµî°ñ°üÀý.
  • intercarpal joint
    ¼Õ¸ñ»À»çÀ̰üÀý
  • intermediate tarsometatarsal joint cavity
  • intermetacarpal joint
    ¼ÕÇ㸮»À»çÀ̰üÀý
  • interphalangeal joint
    Áö°£ °üÀý, Áö°ñ°£ °üÀý(ò¦ÍéÊàμï½), IP °üÀý.
  • interphalangeal joint
    Áö°ñ°£°üÀý(ò¦ÍéÊàμï½), IP °üÀý.
  • interphalangeal joint
    ¼Õ°¡¶ô»À»çÀ̰üÀý
  • intervertebral joint complex
    Ãß°£ °üÀý º¹ÇÕ(õÐÊàμï½ÜÜùê).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
AJCC American Joint Commission for Cancer
AJCCS American Joint Committee on Cancer Staging
AJS acute joint syndrome
CMCJ carpometacarpal joint
CMJ carpometacarpal joint
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
LJM Limited Joint Mobility
PIP Proximal interphalangeal joint
SIJ Sacroiliac joint
TMJ Temporomandibular Joint
TMJDS Temporomandibular Joint Disturbance Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tarsal joint
    Á· °üÀý
    ¹ß¿¡ ÀÖ´Â ¸ðµç °üÀýÀÇ ÃÑĪ.
  • temporomandibular joint
    ÃøµÎÇϾǰüÀý
  • temporomandibular joint arthropathy
    ¾Ç°üÀý º´º¯
    ¾Ç°üÀýÀÇ °¡Àå ÈçÇÑ Àå¾Ö´Â Dolwick¿¡ ÀÇÇØ Á¤ÀÇµÈ ³»ÀåÁõÀ¸·Î À̰ÍÀº ÇÏ¾Ç °úµÎ³ª ÇÏ¾Ç¿Í °üÀý À¶±â¿¡ ´ëÇÑ °üÀý ¿øÆÇÀÇ ºñÁ¤»óÀû °ü°èÀÌ´Ù.
  • temporomandibular joint disease
    ÃøµÎÇϾǰüÀý Áúȯ
  • temporomandibular joint dysfunction
    ÃøµÎÇϾǰüÀý ±â´É Àå¾Ö, ¾Ç°üÀý ±â´É ÀÌ»ó
    ÃøµÎÇϾǰüÀýÀÇ ºñÁ¤»óÀûÀÌ°í ºÒ¿ÏÀüÇϸç Àå¾Ö°¡ ÀÖ´Â ±â´É.
  • temporomandibular joint hypermobility
    ÃøµÎÇϾǰüÀý °ú¿îµ¿, ÃøµÎÇϾǰüÀý °ú¿îµ¿Áõ
    ÃøµÎÇϾǰüÀýÀÇ °úµµÇÑ ¿îµ¿.
  • temporomandibular joint remodeling
    ¾Ç°üÀýÀÇ ¸®¸ðµ¨¸µ
  • temporomandibular joint syndrome
    ÃøµÎÇϾǰüÀý ÁõÈıº, ¾Ç°üÀýÁõ
    1. ºÎºÐÀû ³­Ã», ±Ó¼ÓÀÇ ¸·Èù°¨, À̸í, ÃøµÎÇϾǰüÀýÀÇ Â©±î´ÚÇÏ´Â ¼Ò¸®¿Í, Çö±âÁõ, µÎÅë, ±×¸®°í ±Í, ÀÎÈÄ, Çô, ÄÚÀÇ ÀÛ¿­Åë µîÀÇ ÁõÈıºÀ¸·Î, ¿©·¯ °¡Áö ¿øÀÎÀÌ Á¦½ÃµÇ¾î ÀÖ´Ù. Áï, ÇϾÇÀÇ °úÀ× ±³ÇÕ, ÃøµÎÇϾǰüÀýÀÇ º´¼Ò¿Í ½ºÆ®·¹½º µîÀÌ´Ù. ±×·¯³ª ¾î¶² ¿¬±¸ÀÚ´Â ÀÌ ÁõÈıºÀ» Áõ¸íÇÒ ¸¸ÇÑ ÇØºÎÇÐÀû ¹× »ý¸®ÇÐÀû Áõ°Å°¡ ¾ø´Ù°í ÇÑ´Ù.
  • terminal closing clicking joint noise
    Æó±¸ ¸»±âÀÇ ´Ü¼ø °üÀý ÀâÀ½
  • tinner joint µµÀç ÀçŶ°üÀ» ¹é±Ý ¸ÅÆ®¸¯½º¸¦ ÀÌ¿ëÇÏ¿© Á¦ÀÛÇÒ ¶§, Áö´ëÄ¡ÀÇ ¼³¸é ¶Ç´Â ÀÎÁ¢¸é¿¡¼­ ¹é±Ý ¸ÅÆ®¸¯½º¸¦ Ä¡¾Æ ÀåÃà ¹æÇâÀ¸·Î Á¢¾î¼­ ¿¬°á½ÃŰ´Â ¹æ¹ýÀÌ´Ù.

    tinnitus

    À̸í, À̸íÁõ, ±Í¿ïÀ½
    µ¿ÀǾî=ear noises, ear ringing. 1. À®À®°Å¸®¸ç ±Ó¼Ó¿¡¼­ ³ª´Â ÀâÀ½. ÀÌ¿Í °°Àº ¼Ò¸®´Â ¶§·Î´Â ȯÀÚº¸´Ùµµ ŸÀο¡ ÀÇÇØ¼­ µé¸®´Â °æ¿ìµµ ÀÖ´Ù. û½Å°æ¿¡ ÀÌ»óÀÌ ÀÖ´Â °æ¿ì°¡ ¸¹´Ù. 2. ±Í³ª ¸Ó¸®¿¡¼­ÀÇ ÁÖ°üÀûÀÎ ¿ï¸²
  • toe joint
    ¹ß°¡¶ô °üÀý
  • unstable joint
    ºÒ¾ÈÁ¤ °üÀý
  • zygapophysial joint
    µ¹±â »çÀÌ °üÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
Langenbeck, Bernhard von <person> German surgeon, 1810-1887.
See: Langenbeck's triangle.
(05 Mar 2000)
Fraunhofer, Joseph von <person> German optician, 1787-1826.
See: Fraunhofer's lines.
(05 Mar 2000)
Frerichs, Friedrich von <person> German pathologist and clinician, 1819-1885.
See: Frerichs' theory.
(05 Mar 2000)
Frey, Max von <person> German physician, 1852-1932.
See: Frey's hairs.
(05 Mar 2000)
Lenhossek, Michael von <person> Hungarian anatomist, 1863-1937.
See: Lenhossek's processes.
(05 Mar 2000)
Leydig, Franz von <person> In 1855 was appointed Professor of Histology in Wurzburg and later in Tubingen and Bonn. Was the founder of Comparative Histology.
Leydig's Cells - interstitial cells of the testis.
Lived: 1821-1908. B. Rothenburg, May 21st, 1821, d. Apr 13th, 1908.
(05 Dec 1998)
Liebermann, Leo von <person> Hungarian physician, 1852-1926.
See: Burchard-Liebermann reaction, Liebermann-Burchard test.
(05 Mar 2000)
Liebermeister, Carl von <person> German physician, 1833-1901.
See: Liebermeister's rule.
(05 Mar 2000)
Liebig, Baron Justus von <person> German chemist, 1803-1873.
See: Liebig's theory.
(05 Mar 2000)
lindau-von hippel syndrome <syndrome> The cardinal features of what is more commonly called von hippel-lindau (vhl) syndrome are benign blood-vessel tumours that most typically affect the eye and the brain. The eye tumours are termed angiomata and are in the retina. The brain tumours are termed haemangioblastoma and are in the cerebellum. Vhl is complex. There can also be blood-vessel tumours (haemangiomata) in the spinal cord, adrenal glands, liver, and lungs. Pheochromocytoma (a benign tumour of adrenal-like tissue) occurs in some patients. The combination of high blood pressure (hypertension) with angioma may cause bleeding under the skull (subarachnoid haemorrhage). Kidney tumours (like hypernephromas) may be malignant and metastasize. An abnormal elevation of red blood cells (polycythemia) can be due to the haemangioblastoma of the cerebellum or the hypernephroma. Multiple cysts can occur in the pancreas and kidneys. Patients with kidney problems or pancreatic cysts do not have pheochromocytoma, and visa versa. Lab findings in vhl may include high calcium (hypercalcaemia) and low potassium (hypokalaemia) occurring with the pheochromocytoma. Vhl is inherited as an autosomal dominant trait. The gene on one of the non-sex chromosomes is dominant over the normal gene with which it is paired so that one vhl gene is sufficient to cause the vhl syndrome. If a person has vhl, the chance for each of their children to receive the vhl gene is one-half (50%). The vhl gene has been mapped to chromosome 3 (the 3rd volume in the book of life) in region 3p26-p25. The vhl gene has the characteristics of a tumour-suppressor gene. The person with vhl inherits one inactive copy of the vhl gene (a germline mutation) from one of their parents. But the normal gene with which it is paired is still enough to suppress the formation of a tumour. Then, in one cell in the vhl patient's body, another mutation (a somatic mutation) occurs, inactivating the other vhl gene. Thus, both copies of the vhl gene are inactivated and a tumour arises in the vhl patient. The syndrome is named for the german ophthalmologist eugen von hippel who described the charcteristic eye blood-vessel tumours in 1904 and the swedish pathologist arvid lindau who recognised the association between the eye tumours and the blood-vessel tumours of the cerebellum and other parts of the central nervous system in 1926-7.
(12 Dec 1998)
Ludwig, Wilhelm Friedrich von <person> German surgeon, 1790-1865.
See: Ludwig's angina.
(05 Mar 2000)
acromioclavicular joint The joint formed by the acromion of the scapula and the acromial extremity of the clavicle.
(12 Dec 1998)
ankle joint The joint that is formed by the inferior articular and malleolar articular surfaces of the tibia, the malleolar articular surface of the fibula, and the medial malleolar, lateral malleolar, and superior surfaces of the talus.
(12 Dec 1998)
anterior intraoccipital joint Cartilaginous union in the newborn between the lateral and the basilar portions of the occipital bone.
Synonym: synchondrosis intraoccipitalis anterior, anterior intraoccipital joint.
(05 Mar 2000)
arthrodial joint A synovial joint in which the opposing surfaces are nearly planes and in which there is only a slight, gliding motion, as in the intermetacarpal joints.
Synonym: articulatio plana, arthrodia, arthrodial articulation, arthrodial joint, gliding joint.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á